STOK
USDStoke Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$25.000
Kõrge
$25.550
Madal
$24.660
Maht
0.81M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.4B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.17M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 30. okt 2025Stoke Therapeutics (STOK): Riding Wave of Biotech Optimism, But Risks Lurk
Price Action: Volatility With Clear Upside Momentum
The stock has swung between $12.40 and $38.69 over the past 90 days, reflecting high sensitivity to news. Key patterns:
- Explosive breakout in October (up 34% from $20.68 to $27.31 in 4 days, then a dramatic spike to $38.69 on Oct 16)
- Recent correction (-4.3% from Oct 22 to 29) followed by a small rebound on Oct 30 (closing at $31.66 vs. $31.41 open)
- Volume surged to 4x average during the October rally, showing strong institutional interest
News Impact: Positive Clinical Data Drives Surge
Three catalysts fueled the October rally:
Seotud uudised
BTIG Reiterates Buy on Stoke Therapeutics, Maintains $39 Price Target
BTIG analyst Thomas Shrader reiterates Stoke Therapeutics with a Buy and maintains $39 price target.
JP Morgan Maintains Neutral on Stoke Therapeutics, Raises Price Target to $25
JP Morgan analyst Jessica Fye maintains Stoke Therapeutics with a Neutral and raises the price target from $15 to $25.
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 5. nov 2025, 09:53
69.8% Kindlus
Risk ja kauplemine
Sisenemispunkt
$29.88
Võta kasum
$32.14
Peata kahjum
$27.01
Põhitegurid
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.